The next era of healthspan will not be built by science alone. It will require collaboration among researchers, clinicians, innovators, investors, advocates, caregivers, policymakers, and the communities they serve. That is the purpose of the Translational Longevity Summit, October 7–11, during Boston Longevity Week.
Hosted at One Milestone, Enterprise Research Campus at Harvard, the Summit is co-organized by the Healthspan Action Coalition, Boston BioLife, Regenerative Medicine Foundation, and The World Stem Cell Summit.
We are especially honored to welcome HRH Dr. Haya Al Saud of the Hevolution Foundation as Guest of Honor. Dr. Haya will deliver a keynote address and participate in sessions examining critical areas including metabolic health and women’s health.
The program also features outstanding voices in longevity science and healthspan innovation:
- Dr. David Barzilai, program co-chair and keynote speaker, presenting “The Longevity Dividend: Turning the Coming Age Wave into the Greatest Opportunity.”
- Dr. Camillo Ricordi, internationally recognized diabetes expert and stem-cell scientist, presenting “Healthspan Engineering to Prevent the Collapse of Reactive Health Systems.”
- Dr. Fiona Miller, scientist and investor, exploring “Key Trends in Longevity Science and the Market.”
- Dr. Derya Unutmaz, scientist and futurist, forecasting “Robots, AI, and Healthspan.”
The Summit is intentionally designed to foster substantive discussion and meaningful connections among people positioned to advance the healthspan field. It’s the single meeting to connect all the dots.
Healthspan for All is more than a slogan—it is the central challenge and opportunity of our time.
Registration remains open, and a limited number of exhibit opportunities are still available. Join us in Boston for five days of science, strategy, collaboration, and practical momentum toward healthier aging.
Register: healthspanaction.org/translational-longevity-summit
